These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 27105530)

  • 1. Increased reactive oxygen species and exhaustion of quiescent CD34-positive bone marrow cells may contribute to poor graft function after allotransplants.
    Kong Y; Song Y; Hu Y; Shi MM; Wang YT; Wang Y; Zhang XH; Xu LP; Liu KY; Deng HK; Huang XJ
    Oncotarget; 2016 May; 7(21):30892-906. PubMed ID: 27105530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysfunctional Bone Marrow Mesenchymal Stem Cells in Patients with Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation.
    Song Y; Zhao HY; Lyu ZS; Cao XN; Shi MM; Wen Q; Tang FF; Wang Y; Xu LP; Zhang XH; Huang XJ; Kong Y
    Biol Blood Marrow Transplant; 2018 Oct; 24(10):1981-1989. PubMed ID: 29933074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An unbalanced monocyte macrophage polarization in the bone marrow microenvironment of patients with poor graft function after allogeneic haematopoietic stem cell transplantation.
    Zhao HY; Lyu ZS; Duan CW; Song Y; Han TT; Mo XD; Wang Y; Xu LP; Zhang XH; Huang XJ; Kong Y
    Br J Haematol; 2018 Sep; 182(5):679-692. PubMed ID: 29974948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impairment of bone marrow endothelial progenitor cells in acute graft-versus-host disease patients after allotransplant.
    Cao XN; Kong Y; Song Y; Shi MM; Zhao HY; Wen Q; Lyu ZS; Duan CW; Wang Y; Xu LP; Zhang XH; Huang XJ
    Br J Haematol; 2018 Sep; 182(6):870-886. PubMed ID: 29984829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of an impaired bone marrow microenvironment with secondary poor graft function after allogeneic hematopoietic stem cell transplantation.
    Kong Y; Chang YJ; Wang YZ; Chen YH; Han W; Wang Y; Sun YQ; Yan CH; Wang FR; Liu YR; Xu LP; Liu DH; Huang XJ
    Biol Blood Marrow Transplant; 2013 Oct; 19(10):1465-73. PubMed ID: 23879970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant T cell responses in the bone marrow microenvironment of patients with poor graft function after allogeneic hematopoietic stem cell transplantation.
    Kong Y; Wang YT; Cao XN; Song Y; Chen YH; Sun YQ; Wang Y; Zhang XH; Xu LP; Huang XJ
    J Transl Med; 2017 Mar; 15(1):57. PubMed ID: 28292332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-Transplantation Blockade of TNF-α-Mediated Oxygen Species Accumulation Protects Hematopoietic Stem Cells.
    Ishida T; Suzuki S; Lai CY; Yamazaki S; Kakuta S; Iwakura Y; Nojima M; Takeuchi Y; Higashihara M; Nakauchi H; Otsu M
    Stem Cells; 2017 Apr; 35(4):989-1002. PubMed ID: 27753160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The bone marrow microenvironment is similarly impaired in allogeneic hematopoietic stem cell transplantation patients with early and late poor graft function.
    Kong Y; Wang YT; Hu Y; Han W; Chang YJ; Zhang XH; Jiang ZF; Huang XJ
    Bone Marrow Transplant; 2016 Feb; 51(2):249-55. PubMed ID: 26437066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atorvastatin enhances endothelial cell function in posttransplant poor graft function.
    Shi MM; Kong Y; Song Y; Sun YQ; Wang Y; Zhang XH; Xu LP; Liu KY; Huang XJ
    Blood; 2016 Dec; 128(25):2988-2999. PubMed ID: 27769957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic transplantation of positively selected peripheral blood CD34+ progenitor cells from matched related donors.
    Finke J; Brugger W; Bertz H; Behringer D; Kunzmann R; Weber-Nordt RM; Kanz L; Mertelsmann R
    Bone Marrow Transplant; 1996 Dec; 18(6):1081-6. PubMed ID: 8971376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD34+ cells from patients with myelodysplastic syndrome present different p21 dependent premature senescence.
    Xiao Y; Wang J; Song H; Zou P; Zhou D; Liu L
    Leuk Res; 2013 Mar; 37(3):333-40. PubMed ID: 23219618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reconstitution activity of hypoxic cultured human cord blood CD34-positive cells in NOG mice.
    Shima H; Takubo K; Iwasaki H; Yoshihara H; Gomei Y; Hosokawa K; Arai F; Takahashi T; Suda T
    Biochem Biophys Res Commun; 2009 Jan; 378(3):467-72. PubMed ID: 19032938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Durable Engraftment and Excellent Overall Survival After CD34-Selected Peripheral Blood Stem Cell Boost in Pediatric Patients With Poor Graft Function Following Allogeneic Stem Cell Transplantation.
    Fraint E; Farooki S; Klein E; Mauguen A; Prockop SE; Scaradavou A; Curran K; Cancio M; Spitzer B; Boelens JJ; Oved J; Harris A; O'Reilly RJ; Kernan NA
    Transplant Cell Ther; 2023 Jan; 29(1):46.e1-46.e6. PubMed ID: 36210027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poor graft function can be durably and safely improved by CD34+-selected stem cell boosts after allogeneic unrelated matched or mismatched hematopoietic cell transplantation.
    Haen SP; Schumm M; Faul C; Kanz L; Bethge WA; Vogel W
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2241-51. PubMed ID: 26272482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonotypic myeloma cells able to xenograft myeloma to nonobese diabetic severe combined immunodeficient mice copurify with CD34 (+) hematopoietic progenitors.
    Pilarski LM; Belch AR
    Clin Cancer Res; 2002 Oct; 8(10):3198-204. PubMed ID: 12374689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD34+ stem cell augmentation of elutriated allogeneic bone marrow grafts: results of a phase II clinical trial of engraftment and graft-versus-host disease prophylaxis in high-risk hematologic malignancies.
    O'Donnell PV; Jones RJ; Vogelsang GB; Seber A; Ambinder RF; Flinn I; Miller C; Marcellus DC; Griffin C; Abrams R; Braine HG; Grever M; Hess AD; Piantadosi S; Noga SJ
    Bone Marrow Transplant; 1998 Nov; 22(10):947-55. PubMed ID: 9849691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-acetyl-L-cysteine improves bone marrow endothelial progenitor cells in prolonged isolated thrombocytopenia patients post allogeneic hematopoietic stem cell transplantation.
    Kong Y; Shi MM; Zhang YY; Cao XN; Wang Y; Zhang XH; Xu LP; Huang XJ
    Am J Hematol; 2018 Jul; 93(7):931-942. PubMed ID: 29396859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrahepatic transplantation of CD34+ cord blood stem cells into newborn and adult NOD/SCID mice induce differential organ engraftment.
    Wulf-Goldenberg A; Keil M; Fichtner I; Eckert K
    Tissue Cell; 2012 Apr; 44(2):80-6. PubMed ID: 22197619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of TNFα to Improve Human CD34+ Cell Repopulating Activity in Allogeneic Stem Cell Transplantation.
    Senyuk V; Patel P; Mahmud N; Rondelli D
    Front Immunol; 2018; 9():3186. PubMed ID: 30723481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poor graft function after allogeneic hematopoietic stem cell transplantation-an old complication with new insights
    Kong Y
    Semin Hematol; 2019 Jul; 56(3):215-220. PubMed ID: 31202433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.